Log in to save to my catalogue

Evaluation of Vero-cell-derived simian endogenous retrovirus infection in humans by detection of vir...

Evaluation of Vero-cell-derived simian endogenous retrovirus infection in humans by detection of vir...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1790961530

Evaluation of Vero-cell-derived simian endogenous retrovirus infection in humans by detection of viral genome in clinicopathological samples and commercialized vaccines and by serology of Japanese general population

About this item

Full title

Evaluation of Vero-cell-derived simian endogenous retrovirus infection in humans by detection of viral genome in clinicopathological samples and commercialized vaccines and by serology of Japanese general population

Publisher

Netherlands: Elsevier Ltd

Journal title

Vaccine, 2016-05, Vol.34 (24), p.2700-2706

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Ltd

More information

Scope and Contents

Contents

Highlights • 783 Human clinicopathological samples were negative for SERV genomes. • 13 Commercialized vaccines were negative for SERV genomes. • Eight of 1000 (0.8%) Japanese individuals were seropositive for SERV. • SERV infection is very rare in humans. • SERV infection is unlikely to be associated with vaccines used in Japan.

Alternative Titles

Full title

Evaluation of Vero-cell-derived simian endogenous retrovirus infection in humans by detection of viral genome in clinicopathological samples and commercialized vaccines and by serology of Japanese general population

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1790961530

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1790961530

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2016.04.031

How to access this item